Piper Sandler Increases Intuitive Surgical (NASDAQ:ISRG) Price Target to $435.00

Intuitive Surgical (NASDAQ:ISRG) had its price objective upped by Piper Sandler from $425.00 to $435.00 in a research report report published on Friday morning, Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock.

ISRG has been the subject of several other research reports. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an outperform rating in a research note on Wednesday, January 24th. Truist Financial upped their price objective on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a buy rating in a research note on Wednesday, January 24th. StockNews.com cut shares of Intuitive Surgical from a buy rating to a hold rating in a research note on Thursday, February 29th. Citigroup upped their price objective on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a buy rating in a research note on Wednesday, April 3rd. Finally, BTIG Research upped their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a buy rating in a research note on Friday. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of $396.17.

Intuitive Surgical Stock Up 0.7 %

ISRG stock opened at $368.93 on Friday. The stock has a market capitalization of $130.77 billion, a P/E ratio of 66.59, a P/E/G ratio of 5.69 and a beta of 1.36. The firm has a 50-day simple moving average of $386.57 and a 200-day simple moving average of $344.41. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s quarterly revenue was up 11.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.00 earnings per share. On average, analysts expect that Intuitive Surgical will post 4.93 earnings per share for the current year.

Insider Activity

In other news, EVP Robert Desantis sold 20,296 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $393.80, for a total value of $7,992,564.80. Following the transaction, the executive vice president now directly owns 5,507 shares in the company, valued at approximately $2,168,656.60. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, SVP Mark Brosius sold 196 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 20,296 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the completion of the transaction, the executive vice president now owns 5,507 shares in the company, valued at $2,168,656.60. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock valued at $95,927,097 in the last 90 days. Company insiders own 0.80% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Large investors have recently made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. boosted its position in Intuitive Surgical by 0.9% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 105,613 shares of the medical equipment provider’s stock valued at $42,149,000 after buying an additional 898 shares during the period. Sapient Capital LLC boosted its position in Intuitive Surgical by 0.4% in the 1st quarter. Sapient Capital LLC now owns 77,813 shares of the medical equipment provider’s stock valued at $31,054,000 after buying an additional 293 shares during the period. Strategic Financial Concepts LLC purchased a new position in Intuitive Surgical in the 1st quarter valued at approximately $263,000. Confluence Wealth Services Inc. boosted its position in Intuitive Surgical by 11.0% in the 1st quarter. Confluence Wealth Services Inc. now owns 666 shares of the medical equipment provider’s stock valued at $266,000 after buying an additional 66 shares during the period. Finally, PFG Investments LLC boosted its position in Intuitive Surgical by 45.2% in the 1st quarter. PFG Investments LLC now owns 2,793 shares of the medical equipment provider’s stock valued at $1,115,000 after buying an additional 870 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.